DistantNews
Support us
🇹🇼 Taiwan /Economy & Trade

PharmaEssentia stock surges past AOP arbitration concerns, netizens eye record high

From Liberty Times · () Chinese

Translated from Chinese, summarized and contextualized by DistantNews.

At a glance

News Sources not specified Context piece
  • Pharmaceutics company PharmaEssentia's stock surged to 1460 New Taiwan dollars, nearing the daily limit, despite recent negative arbitration news.
  • The company stated that the arbitration ruling from the International Chamber of Commerce (ICC) International Court of Arbitration has no significant impact on its finances or business.
  • Investors appear unfazed by the arbitration outcome, with online discussions showing optimism about the stock challenging its previous high of 1570 New Taiwan dollars.

PharmaEssentia's stock price continued its strong upward trend on August 11, opening at a flat 1330 New Taiwan dollars before surging to a high of 1460 dollars as buying pressure mounted. The rally, just shy of the daily limit, has sparked lively discussion among investors and online communities.

These two days of gains are enough to prove that AOP has become a thing of the past.

— NetizenOnline discussion about PharmaEssentia's stock performance after the arbitration ruling.

The company had recently drawn market attention due to an arbitration case with international pharmaceutical firm AOP. On August 8, PharmaEssentia held a press conference to explain a "partial award" from the ICC, acknowledging that some aspects of the ruling were unfavorable. However, the company emphasized that the arbitration decision does not significantly affect its financial or business operations and that it is considering an appeal to revoke the award.

After the AOP incident, it directly responded with almost two limit-ups. AOP is actually seen as a puff of air.

— NetizenOnline discussion about PharmaEssentia's stock performance after the arbitration ruling.

Despite initial concerns that the arbitration outcome might weigh on the stock, PharmaEssentia's shares showed resilience on August 10, recovering from an early 4% drop to close strongly. The continued upward momentum on August 11 suggests that the market's reaction to the negative arbitration news is fading. Online, many users expressed confidence, with one stating that the recent gains prove the AOP issue is "in the past." Another commented that the stock's performance after the AOP event was like "two limit-up days," dismissing the arbitration as insignificant given the strength of the new drug.

The stock price of PharmaEssentia is getting higher and higher, and will challenge the previous high of 1570 yuan.

— NetizenOnline discussion about PharmaEssentia's stock price outlook.

Optimism for PharmaEssentia's future is high, with some investors predicting the stock will challenge its previous record of 1570 dollars and even reach 2000 dollars soon. The company's robust performance indicates a strong market belief in its underlying value and future prospects, overshadowing the recent legal dispute.

Everyone is holding tight, and we will see 2000 soon.

— NetizenOnline discussion about PharmaEssentia's stock price outlook.
DistantNews Editorial

Originally published by Liberty Times in Chinese. Translated, summarized, and contextualized by our editorial team with added local perspective. Read our editorial standards.

More Stories

From Our Blog